Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 205869
Company: BEIJING YILING

Products on ANDA 205869

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
LETROZOLE	LETROZOLE	2.5MG	TABLET;ORAL	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 205869

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
11/14/2018	ORIG-1	Approval		STANDARD		Label is not available on this site.

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
08/15/2025	SUPPL-8	Labeling-Package Insert		Label is not available on this site.

Therapeutic Equivalents for ANDA 205869

LETROZOLE

TABLET;ORAL; 2.5MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
FEMARA	LETROZOLE	2.5MG	TABLET;ORAL	Prescription	Yes	AB	020726	NOVARTIS PHARMS
LETROZOLE	LETROZOLE	2.5MG	TABLET;ORAL	Prescription	No	AB	090934	ACCORD HLTHCARE
LETROZOLE	LETROZOLE	2.5MG	TABLET;ORAL	Prescription	No	AB	205869	BEIJING YILING
LETROZOLE	LETROZOLE	2.5MG	TABLET;ORAL	Prescription	No	AB	211717	EUGIA PHARMA
LETROZOLE	LETROZOLE	2.5MG	TABLET;ORAL	Prescription	No	AB	200161	NATCO PHARMA LTD
LETROZOLE	LETROZOLE	2.5MG	TABLET;ORAL	Prescription	No	AB	090289	TEVA PHARMS